SynthesisFrontiers in physiology2026
Compartment-specific oxidative stress signatures in oral leukoplakia: a systematic review of local and systemic biomarkers.
Synthesis in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral leukoplakia (OLK) is one of the most common potentially malignant disorders of the oral mucosa. Oxidative stress is increasingly recognized as a key factor in its pathogenesis and malignant transformation, but the consistency of biomarker alterations across biological compartments remains unclear. Aim: To evaluate compartment-specific oxidative stress alterations across local (tissue, saliva) and systemic (blood, plasma, serum) environments in OLK by synthesizing evidence on biomarker levels in these biological compartments. Materials and methods: A systematic search was conducted in PubMed, Web of Science and Scopus, following PRISMA guidelines. Studies were included if they compared oxidative stress biomarkers between OLK patients and healthy controls. Data were qualitatively synthesized, and study quality was assessed using the Newcastle-Ottawa Scale, ROBINS-I (Cochrane), and AXIS. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under registration number CRD42023438437. Results: Fifteen studies were included (n = 804). Oxidative damage markers such as malondialdehyde (MDA) and 8-OHdG were consistently elevated in OLK patients across tissue, serum, plasma, blood, and saliva. Enzymatic antioxidants such as GPx, SOD, and CAT were generally reduced, whereas tissue levels of glutathione (GSH) were elevated, suggesting a local compensatory response. Total antioxidant capacity (TAS/TAC) was decreased systemically. Notably, antioxidant responses differed across biological compartments, with increased tissue GSH contrasting with systemic depletion. Conclusion: The available evidence supports a consistent redox imbalance in OLK characterized by increased oxidative damage and impaired systemic antioxidant defenses. Salivary and serum biomarkers, particularly MDA and 8-OHdG, show promise as non-invasive indicators of oxidative stress and disease progression. However, methodological heterogeneity and small sample sizes limit clinical translation. Standardized protocols and longitudinal studies are needed to validate these biomarkers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.